ReviewVascular health and risk management2012

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.

Massimo Volpe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.